Highlights

AmInvest Research Reports

Author: AmInvest   |   Latest post: Wed, 12 May 2021, 9:12 AM

 

Malayan Cement - Proposes private placement of 10% new shares

Author:   |    Publish date:


Investment Highlights

  • We maintain our BUY recommendation and forecasts, but slightly increase our fair value to RM3.36/share (from RM3.29) to reflect the recent US$’s strength. Our FV is based on US$108 per clinker tonne (8.2mil clinker capacity x US$108 x RM4.12:US$1 minus RM833mil net debt), at a 10% discount to the replacement cost of US$120 to reflect the still changing cement sector outlook in Peninsular Malaysia. There is no adjustment for ESG based on a 3-star rating as appraised by us (Exhibit 2).
  • Malayan Cement has proposed a private placement of new shares of up to 10% of its outstanding shares or 85mil shares at an indicative issue price of RM2.67/share. Based on our estimates, net proceeds of RM224mil will reduce Malayan Cement’s net debt and gearing of RM793.2mil and 0.35x as at 31 Dec 2020 to RM569.2mil and 0.25x. The exercise shall also resolve Malayan Cement’s outstanding share free float issue as it will increase the Malayan Cement’s public shareholding spread to 30.0% (from 23% currently).
  • Given that Malayan Cement is still in its early stages of earnings recovery, our calculation shows that the exercise will not be EPS dilutive, but instead boost its FY21F EPS by 2%, as a 13% earnings enhancement arising from interest savings (based on an interest rate of 5%) more than offset a 10% expansion in the share base.
  • Nonetheless, the exercise will be slightly FV dilutive (given that the indicative issue price is lower than our existing FV). Post the exercise, our FV shall fall marginally to RM3.29 based on the same asset-based valuation method.
  • We maintain our cement per tonne ASP assumptions of RM260, RM270 and RM280 in FY21–23F. For sales volumes, we assume 4.2mil tonnes, 4.4mil tonnes and 4.5 tonnes respectively during the same period. While we believe the worst is behind the cement sector in Peninsular Malaysia (thanks largely to the sector consolidation), the recovery will be gradual given the still weak outlook for its two main consuming industries, i.e. property and construction.
  • We now see more rational competition amongst players in the cement sector in Peninsular Malaysia and they are on the verge of a turnaround, followed with sustained profitability.
  • At its current share price, the market is effectively valuing Malayan Cement at about 15% discount to its replacement cost (based on the replacement cost for clinker capacity of US$120/tonne). We believe 10% is a more appropriate level.

Source: AmInvest Research - 16 Apr 2021

Share this
Labels: MCEMENT

Related Stocks

Chart Stock Name Last Change Volume 
MCEMENT 2.75 0.00 (0.00%)

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program
 
 

64  75  428  1947 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 TANCO 0.1350.00 
 NOVAMSC 0.115-0.01 
 FOCUS 0.0650.00 
 TANCO-WB 0.06+0.01 
 MCT 0.225-0.01 
 BJCORP-WB 0.045-0.005 
 KANGER 0.075+0.005 
 LKL 0.355-0.005 
 SUPERMX-HF 0.090.00 
 PHB 0.020.00 

FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. OCK - The Unfaltering Tower OCK - The 5G Battle
2. FCPO FOR MAY 2021 NOW IS RM4,880 (TIME WHEN ALL GOES DOWN PALM OIL UP: SO BUY PALM OIL SHARES ON SALE, Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
3. Can this penny stock double in value this year? Swim With Sharks
4. 马银行大会圆满落幕/万年船 小股东大权利
5. TWO POWERFUL FACTORS WHY PALM OIL BULL RUN CAN LAST MUCH LONGER THIS ROUND, Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. Genting Bhd - A Soft 1QFY21 at GENS Kenanga Research & Investment
7. 这家小型股的股价在今年还可以再翻倍吗? Swim With Sharks
8. The Competitive Edge of NEXGRAM (0096) in Vaccine Passports and Digital Facilitation Services: THE NEW GEM IN HEALTHCARE Nexgram (0096) - THE NEW GEM IN HEALTHCARE
PARTNERS & BROKERS